Skip to content

The diagnostic value of magnifying endoscopy combined with narrow-band light imaging in type 1 gastric neuroendocrine tumor in the background of autoimmune gastritis

The diagnostic value of magnifying endoscopy combined with narrow-band light imaging in type 1 gastric neuroendocrine tumor in the background of autoimmune gastritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097874
Enrollment
Unknown
Registered
2025-02-26
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric neuroendocrine tumor type 1 in the background of autoimmune gastritis

Interventions

Gold Standard:pathological diagnosis
Index test:Magnifying endoscopy combined with narrow-band light imaging

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Previous clinical diagnosis of AIG, that is, meet the following two points: 1)Signs of gastric atrophy were found in previous endoscopy, or histopathology confirmed the existence of gastric atrophy; 2)Aig-associated autoantibodies are positive (anti-parietal cell antibodies or anti-internal factor antibodies, either or both). 2.The previous pathological diagnosis of gNET.

Exclusion criteria

Exclusion criteria: (1) Age < 18 years old; (2) the patient's informed consent cannot be obtained; (3) Patients who have previously undergone partial or total removal of the stomach; (4) Those with severe heart, liver, kidney or lung diseases; (5) Pregnant and lactating women; (6) Patients who cannot tolerate gastroscopy; (7) combined with mental illness; (8) Antithrombotic drugs are being used; (9) Severe underlying infection; (10) Emergency endoscopy.

Design outcomes

Primary

MeasureTime frame
True positive outcome;True negative outcome;False negative outcome;False positive outcome;Accuracy;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactJinlin Yang

West China Hospital, Sichuan University

yangjinlin@wchscu.cn+86 189 8060 2058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026